Comparison of two systemic steroid regimens for the treatment of COPD exacerbations

Pulmonary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2014, Pages 179-183

  Ceviker, Yelda ^a,b   Sayiner, Abdullah ^a  

^a EGE UNIVERSITY   (Turkey)

^b State Hospital   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Systemic glucocorticoid; Treatment

Indexed keywords

METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; OXYGEN;

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL READMISSION; HUMAN; HYPERCAPNIA; HYPERGLYCEMIA; HYPERTENSION; LENGTH OF STAY; LOW DRUG DOSE; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY FAILURE; COMPARATIVE STUDY; DOSE RESPONSE; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SINGLE BLIND PROCEDURE;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; METHYLPREDNISOLONE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SINGLE-BLIND METHOD;

EID: 84895921015     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.03.004     Document Type: Article

References (14)

1. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
2. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
3. Connors A.F., Dawson N.V., Thomas C., Harrell F.E., Desbiens N., Fulkerson W.J., et al. Outcomes following acute exacerbationof severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996, 154:959-967.
4. Patil S.P., Krishnan J.A., Lechtzin N., Diette G.B. In-hospital mortality folllowing acute exacerbationof chronic obstructive pulmonary disease. Arch Intern Med 2003, 163:1180-1186.
5. Global strategy for the diagnosis, management and prevention of COPD (revised 2011). http://www.goldcopd.org.
6. Aaron S.D., Vandemheen K.L., Hebert P., Dales S., Stiell I.G., Ahuja J., et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. NEngl J Med 2003, 348:2618-2625.
7. Thompson W.H., Nielson C.P., Carvalho P., Charan N.B., Crowley J.J. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996, 154:407-412.
8. Davies L., Angus R.M., Calverley P.M. Oral corticosteriods in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999, 354:456-460.
9. Niewoehner D.E., Erbland M.L., Deupree R.H., Collins D., Gross N.J., Light R.W., et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. NEngl J Med 1999, 340:1941-1947.
10. Maltais F., Ostinelli J., Bourbeau J., Tonnel A.B., Jacquemet N., Haddon J., et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomined controlled trial. Am J Respir Crit Care Med 2002, 165:698-703.
11. de Jong Ynze P., Uil Steven M., Grotjohan Hans P., Postma Dirkje S., Kerstjens Huib A.M., van den Berg Jan W.K. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest 2007, 132:1741-1747.
12. Al-Habet S., Rogers H.J. Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol 1980, 10:503-508.
13. Sayiner A., Aytemur Z.A., Cirit M., Ünsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001, 119:726-730.
14. Lindenauer P.K., Pekow P.S., Lahti M.C., Lee Y., Benjamin E.M., Rothberg M.B. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAm Med Assoc 2010, 303:2359-2367.